AB 2522: Sales and Use Tax Law: exemption: over-the-counter medication.
This bill would exempt over-the-counter medication from state sales and use tax until January 1, 2032. The exemption would apply to the sale and use of medication in California, but not to local sales and use taxes or transactions and use taxes. Additionally, the exemption would not affect state sales and use tax rates dedicated for local government funding. The bill would take effect immediately as a tax levy, and it would require findings and performance indicators to be included in future legislation authorizing the tax expenditure.
| Apr. 27, 2026 | In committee: Set, second hearing. Held under submission. |
| Apr. 06, 2026 | In committee: Set, first hearing. Referred to REV. & TAX. suspense file. |
| Mar. 09, 2026 | Referred to Com. on REV. & TAX. |
| Feb. 21, 2026 | From printer. May be heard in committee March 23. |
| Feb. 20, 2026 | Read first time. To print. |
| Introduced by Assembly Member Jeff Gonzalez |
February 20, 2026 |
LEGISLATIVE COUNSEL'S DIGEST
The people of the State of California do enact as follows:
SECTION 1.
Section 6369.3 is added to the Revenue and Taxation Code, to read:6369.3.
(a) For purposes of this section, “over-the-counter medication” means a nonprescription drug regulated by the Food and Drug Administration pursuant to the federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 301 et seq.) and federal regulations adopted pursuant to that act, including, but not limited to, Part 211 of Title 21 of the Code of Federal Regulations.SEC. 2.
This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.